Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate in Symptomatic Uterine Fibroids
NCT04132349Phase 4Terminated
- Sponsor
- My Duc Hospital
- Start
- Oct 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ulipristal in Uterine Fibroids (UF), sponsored by My Duc Hospital. Primary endpoint: Amenorrhea at 3 months. Started Oct 2019; status: terminated.
02
Drugs
ulipristal
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT04132349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04132349.